XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
Net revenues
 9 Months Ended
Sep. 25, 2022
Revenue from Contract with Customer [Abstract]  
Net revenues Net revenuesWe primarily generate revenue from the sale of medical devices including single use disposable devices and, to a lesser extent, reusable devices, instruments and capital equipment. Revenue is recognized when obligations under the terms of a contract with our customer are satisfied; this occurs upon the transfer of control of the products. Generally, transfer of control to the customer occurs at the point in time when our products are shipped from the manufacturing or distribution facility. For our Original Equipment and Development Services ("OEM") segment, most revenue is recognized over time because the OEM segment generates revenue from the sale of custom products that have no alternative use and we have an enforceable right to payment to the extent that performance has been completed. We market and sell products through our direct sales force and distributors to customers within the following end markets: (1) hospitals and healthcare providers; (2) other medical device manufacturers; and (3) home care providers, which constituted 88%, 10% and 2% of consolidated net revenues, respectively, for the nine months ended September 25, 2022. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods. With respect to the custom products sold in the OEM segment, revenue is measured using the units produced output method. Payment is generally due 30 days from the date of invoice.
The following table disaggregates revenue by global product category for the three and nine months ended September 25, 2022 and September 26, 2021.
Three Months EndedNine Months Ended
September 25, 2022September 26, 2021September 25, 2022September 26, 2021
Vascular access$167,147 $175,476 $497,188 $507,188 
Anesthesia97,608 97,074 289,260 277,357 
Interventional108,738 104,304 319,939 312,559 
Surgical93,124 92,831 282,468 271,402 
Interventional urology78,969 83,107 233,682 248,714 
OEM71,288 64,083 198,947 178,528 
Other (1)
69,914 83,376 211,561 251,901 
Net revenues (2)
$686,788 $700,251 $2,033,045 $2,047,649 
(1)Includes revenues generated from sales of our respiratory and urology products (other than interventional urology products). Certain product lines within the respiratory product category were sold during 2021. See Note 4 for additional information related to the Respiratory business divestiture.
(2)    The product categories listed above are presented on a global basis, while each of our reportable segments other than the OEM reportable segment are defined based on the geographic location of its operations; the OEM reportable segment operates globally. Each of the geographically based reportable segments include net revenues from each of the non-OEM product categories listed above.